Which are the causes of Glanzmanns thrombasthenia?

Glanzmanns thrombasthenia is a rare inherited bleeding disorder caused by mutations in the ITGA2B or ITGB3 genes, which prevent platelets from clumping together to form a clot. Because these genetic mutations disrupt the production or function of the GPIIb/IIIa receptor complex, the blood cannot effectively stop bleeding after an injury.

What causes Glanzmanns thrombasthenia at a genetic level?

The primary cause of Glanzmanns thrombasthenia is a genetic defect that affects the platelet surface. Think of platelets as the body's "first responders" to a cut; in a healthy person, these platelets use a specialized "velcro" on their surface, known as the GPIIb/IIIa receptor, to stick to one another. In individuals with Glanzmanns thrombasthenia, mutations in either the ITGA2B gene (which codes for the alpha-IIb subunit) or the ITGB3 gene (which codes for the beta-3 subunit) prevent this "velcro" from forming or functioning correctly. Without this receptor, platelets circulate normally but fail to aggregate, meaning they cannot build a stable plug to stop bleeding.

Is Glanzmanns thrombasthenia an inherited condition?

Yes, Glanzmanns thrombasthenia is an autosomal recessive disorder. This means that an individual must inherit two copies of the mutated gene—one from each parent—to manifest the condition. Parents who each carry one copy of the mutation are typically asymptomatic "carriers" but have a 25% chance with each pregnancy of having a child affected by the disorder. Because it is strictly genetic, there are no environmental triggers, infections, or lifestyle factors that cause the disease; it is present from birth.

What is the difference between the causes and risk factors of Glanzmanns thrombasthenia?

It is important to distinguish between the cause of the disease and risk factors for complications. The cause is exclusively the underlying genetic mutation mentioned above. However, "risk factors" in the context of Glanzmanns thrombasthenia usually refer to external elements that can exacerbate bleeding episodes. These include:

• Use of medications that interfere with platelet function, such as aspirin or non-steroidal anti-inflammatory drugs (NSAIDs).


• Undergoing surgical procedures or dental extractions without specialized hematological preparation.


• High-impact physical activities that increase the risk of trauma or internal bruising.

What is the current state of research into the etiology of this condition?

While the genetic basis of Glanzmanns thrombasthenia is well-understood, researchers are actively investigating why the severity of bleeding varies so significantly between patients, even those with similar mutations. Current studies are focused on:

• Gene Therapy: Exploring ways to introduce functional copies of the ITGA2B or ITGB3 genes into stem cells.


• Genotype-Phenotype Correlation: Mapping specific mutations to clinical outcomes to better predict bleeding risks.


• Platelet Engineering: Developing methods to stimulate the production of functional GPIIb/IIIa complexes.

At DiseaseMaps.org, we have seen 59 people with Glanzmanns thrombasthenia join our community, highlighting the importance of shared experiences in understanding the daily impact of this rare condition as researchers continue to seek more effective, long-term treatments.

Next steps

• Consult with a hematologist who specializes in platelet disorders to develop a personalized "bleeding plan."


• Obtain genetic counseling to understand the inheritance patterns for your family members.


• Join the DiseaseMaps.org community to connect with other families navigating life with Glanzmanns thrombasthenia.


• Carry a medical alert identification card or bracelet at all times to inform emergency medical personnel of your condition.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment; always seek the guidance of your physician regarding any medical condition.

References

• Orphanet: Glanzmann thrombasthenia (ORPHA:832)


• NIH Genetic and Rare Diseases (GARD) Information Center: Glanzmann thrombasthenia


• OMIM (Online Mendelian Inheritance in Man): Thrombasthenia of Glanzmann and Naegeli (#273800)


• National Hemophilia Foundation: Glanzmann’s Thrombasthenia Resources